Characterization of compound missense mutation and deletion of carnitine palmitoyltransferase II in a patient with adenovirus-associated encephalopathy

Journal of Medical Investigation

Volumn 58, Issue 3-4, 2011, Pages 210-218

  Yao, Dengbing ^a   Yao, Min ^a   Yamaguchi, Miyoko ^a   Chida, Junji ^a   Kido, Hiroshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Carnitine palmitoyltransferase II; COS 7 cells; Half life; Missense mutation

Indexed keywords

ACYLTRANSFERASE; ARGININE; CARNITINE PALMITOYLTRANSFERASE II; GLUTAMINE; ISOLEUCINE; METHIONINE; UNCLASSIFIED DRUG; VALINE;

ADENOVIRUS ASSOCIATED ENCEPHALOPATHY; ADENOVIRUS INFECTION; ARTICLE; BRAIN INFECTION; CASE REPORT; CONTROLLED STUDY; CPT2 GENE; ENZYME ACTIVITY; ENZYME STABILITY; GENE; GENE DELETION; HUMAN; MISSENSE MUTATION; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; THERMOSTABILITY; VIRUS PATHOGENESIS;

ADENOVIRIDAE; MAMMALIA;

EID: 80052728414     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.58.210     Document Type: Article

References (35)

1. Mizuguchi M, Yannanouchi H, Ichiyama T, Shiomi M: Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 115 (Suppl. 186): 45-56, 2007
2. Mizuguchi M: Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev 19: 81-92, 1997
3. Sugaya N: Influenza-associated encephalopathy in Japan: pathogenesis and treatment. Pediatr Int 42: 215-218, 2000
4. Shinohara M, Saitoh M, Takahashi J, Yamanouchi H, Kubota M, Goto T, Kikuchi M, Shiihara T, Yamanaka G, Mizuguchi M: Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases. Brain Dev 33: 512-517, 2011
5. Morishima T, Togashi T, Yokota S, Okuno Y, Miyazaki C, Tashiro M, Okabe N: Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 35: 512-517, 2002
6. Chen Y, Mizuguchi H, Yao D, Ide M, Kuroda Y, Shigematsu Y, Yamaguchi S, Yamaguchi M, Kinoshita M, Kido H: Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza-associated encephalopathy. FEBS Lett 579: 2040-2044, 005
7. Yao D, Mizuguchi H, Yamaguchi M, Yamada H, Chida J, Shikata K, Kido H: Thermal instability of compound variants of carnitine palmitoyltransferase II and impaired mitochondrial fuel utilization in influenza-associated encephalopathy. Hum Mutat 29: 718-727, 2008
8. Kubota M, Chida J, Hoshino H, Ozawa H, Koide A, Kashii H, Koyama A, Mizuno Y, Hoshino A, Yamaguchi M, Yao D, Yao M, Kido H: Thermolabile CPT II variants and low blood ATP levels are closely related to severity of acute encephalopathy in Japanese children. Brain Dev PMID: 21277129, 2011
9. Demaugre F, Bonnefont JP, Colonna M, Cepanec C, Leroux JP, Saudubray JM: Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies. J Clin Invest 87: 859-864, 1991
10. Zierz S: Limited trypsin proteolysis renders carnitine palmitoyltransferase insensitive to inhibition by malonyl-CoA in patients with muscle carnitine palmitoyltransferase deficiency. Clin Investig 72: 957-960, 1994
11. Hug G, Bove KE, Soukup S: Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. N Engl J Med 325: 1862-1864, 1991
12. DiMauro S, DiMauro PM: Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 182: 929-931, 1973
13. Taroni F, Verderio E, Fiorucci S, Cavadini P, Finocchiaro G, Uziel G, Lamantea E, Gellera C, DiDonato S: Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. Proc Natl Acad Sci USA 89: 8429-8433,1992
14. Thuillier L, Rostane H, Droin V, Demaugre F, Brivet M, Kadhom N, Prip-Buus C, Gobin S, Saudubray JM, Bonnefont JP: Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 (CPT2) deficiency. Hum Mutat 21: 493-501, 2003
15. Olpin SE, Afifi A, Clark S, Manning NJ, Bonham JR, Dalton A, Leonard JV, Land JM, Andresen BS, Morris AA, Muntoni F, Turnbull D, Pourfarzam M, Rahman S, Pollitt RJ: Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency. J Inherit Metab Dis 26: 543-57, 2003
16. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970
17. McGarry JD, Foster DW: Systemic carnitine deficiency. N Engl J Med 303: 1413-1415, 1980
18. Rufer AC, Thoma R, Benz J, Stihle M, Gsell B, De Roo E, Banner DW, Mueller F, Chomienne O, Hennig M: The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment. Structure 14: 713-723, 2006
19. Isackson PJ, Bennett MJ, Vladutiu GD: Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmi-toyltransferase II deficiency. Mol Genet Metab 89: 323-331, 2006
20. Bonnefont JP, Demaugre F, Prip-Buus C, Saudubray JM, Brivet M, Abadi N, Thuillier L: Carnitine palmitoyltransferase deficiencies. Mol Genet Metab 68: 424-440, 1999
21. Taggart RT, Smail D, Apolito C, Vladutiu GD: Novel mutations associated with carnitine palmitoyltransferase II deficiency. Hum Mutat 13: 210-220, 1999
22. Verderio E, Cavadini P, Montermini L, Wang H, Lamantea E, Finocchiaro G, DiDonato S, Gellera C, Taroni F: Carnitine palmitoyltransferase II deficiency: structure of the gene and characterization of two novel disease-causing mutations. Hum Mol Genet 4: 19-29, 1995
23. Weiser M, Frishman WH, Michaelson MD, Abdeen MA: The pharmacologic approach to the treatment of obesity. J Clin Pharmacol 37: 453-473, 1997
24. Yang BZ, Ding JH, Roe D, Dewese T, Day DW, Roe CR: A novel mutation identified in carnitine palmitoyltransferase II deficiency. Mol Genet Metab 63: 110-115, 1998
25. Yang BZ, Ding JH, Dewese T, Roe D, He G, Wilkinson J, Day DW, Demaugre F, Rabier D, Brivet M, Roe C: Identification of four novel mutations in patients with carnitine palmitoyltransferase II (CPT II) deficiency. Mol Genet Metab 64: 229-236, 1998
26. Wataya K, Akanuma J, Cavadini P, Aoki Y, Kure S, Invernizzi F, Yoshida I, Kira J, Toroni F, Matsubara Y, Narisawa K: Two CPT2 mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency: functional analysis and association with polymorphic haplotypes and two clinical phenotypes. Hum Mutat 11: 377-386, 1998
27. Wang S, Le TQ, Kurihara N, Chida J, Cisse Y, Yano M, Kido H: Influenza virus-cytokineprotease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J Infect Dis 207: 991-1001, 2010
28. Oldendorf WH, Cornford ME, Brown WJ: The large apparent work capability of the bloodbrain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol 1: 409-417,1977
29. Dagher Z, Ruderman N, Tornheim K, Ido Y: Acute regulation of fatty acid oxidation and AMP-activated protein kinase in human umbilical vein endothelial cells. Circ Res 88: 1276-1282,2001
30. Gong Q, Stump MR, Zhou Z: Inhibition of nonsense-mediated mRNA decay by antisense morpholino oligonucleotides restores functional expression of hERG nonsense and frameshif mutations in long-QT syndrome. J Mol Cell Car-diol 50: 223-229, 2011
31. Bieber LL: Carnitine. Annu Rev Biochem 57: 261-283, 1988
32. Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J: Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 25: 495-520, 2004
33. Plateel M, Dehouck MP, Torpier G, Cecchelli R, Teissier E: Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer. J Neurochem 65: 2138-2145, 1995
34. Bradley M, Zeytun A, Rafi-Janajreh A, Nagarkatti PS, Nagarkatti M: Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fastumor cells. Blood 92: 4248-4255,1998
35. Rossignol R, Letellier T, Malgat M, Rocher C, Mazat JP: Tissue variation in the contro of oxidative phosphorylation: implication for mitochondrial diseases. Biochem J 347: 45-53, 2000